Oracle and Cmed reveal eClinical product innovations; Stephen Wolfram presents his firm's "answer engine";

> McGill University and MIT researchers are working together on advanced computational methods for modeling protein folding, which often goes awry in many diseases such as Alzheimer's, Parkinson's and cystic fibrosis. Report 

> Profil Institute for Clinical Research and Rosa & Co. said that they have entered a "strategic alliance" to provide Rosa & Co.'s disease modeling technology to Profil's customers doing early stage clinical development. Release

> Oracle Health Sciences said its "InForm" global trial management (GTM) 5.5 software is now available with product enhancements to increase trial efficiency and the productivity of people running clinical studies. Item

> Cmed Technology said it would preview its Timaeus Guided Trial Builder software later this month an industry meeting to show how the product offers a way to "simplify and streamline the startup of electronic trials." Cmed release

> Bio-IT World provides an overview of a recent speech by Wolfram Research CEO Stephen Wolfram, whose firm created the "answer engine" Wolfram|Alpha, which he called "possibly the most complex software ever assembled." Report

> The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which says it hosts the largest public collection of molecular biology databases in the world, announced that it will use the pan-European GÉANT research network and the U.K. research network called JANET to aid biologists in sharing data globally. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.